This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at firstname.lastname@example.org or call 800-767-3771 ext. 9339.
• Research In Motion Limited (NASDAQ: ( ) reported first quarter earnings per share of $1.33. While this is marginally higher than the Zacks Consensus EPS Estimate of $1.32 per share, revenue numbers missed expectations of $5.4 billion by roughly half a billion dollars, coming in at $4.9 billion
• KV Pharmaceutical Co. (NYSE:KV-A) announced plans to sell its generics subsidiary, Nesher Pharmaceuticals Inc, as well as the company's generic business and assets to Zydus Pharmaceuticals (USA), Inc. for nearly $60 million in cash. The transaction is likely to close in Q2FY12
• BPZ Resources, Inc. (NYSE: ( BPZ - Snapshot Report ) initiated the process to identify and select a partner for its offshore Block Z-1 in northwest Peru
• William Blair initiated coverage on Rockwell Automation Inc. (NYSE: ( ROK - Analyst Report ) with a “Market Perform rating
• Citigroup, Inc. (NYSE: ( C - Analyst Report ) downgraded Celestica Inc. (NYSE: ( CLS - Snapshot Report ) by two notches to “Sell from “Hold rating
• UBS AG (NYSE: ( UBS - Analyst Report ) upgraded CIENA Corp. (NASDAQ: ( CIEN - Analyst Report ) by two notches to “Neutral from “Sell rating
• JPMorgan Chase & Co. (NYSE: ( JPM - Analyst Report ) upgraded InterMune Inc. (NASDAQ: ( ITMN - Snapshot Report ) to “Overweight from “Neutral rating
• Morgan Keegan initiated coverage on Abbott Laboratories (NYSE: ( ABT - Analyst Report ) with an “Outperform rating
Please login to Zacks.com or register to post a comment.